Cancer Immunology


Selected Publications

  • –  BurckhardT.,ThielM.,NishikawaH.,WüestT.,MüllerD., Zippelius A., Ritter G., Old L., Shiku H., Renner C. (2010) Tumor-specific crosslinking of GITR as costimulation for immunotherapy. J Immunotherapy 33, 925-934

  • –  SpeiserD.E.,SchwarzK.,BaumgaertnerP.,ManolovaV., Devevre E., Sterry W., Walden P., Zippelius A., Conzett K.B., Senti G., Voelter V., Cerottini J.P., Guggisberg D., Willers J., Geldhof C., Romero P., Kündig T., Knuth A., Dummer R., Trefzer U., Bachmann M.F.(2010) Memory and effector CD8 T-cell responses after nanoparticle vac- cination of melanoma patients. J Immunother 33, 848-858

  • –  WickiA.,RochlitzC.,OrlethA.,RitschardR.,AlbrechtI., Herrmann R., Christofori G., Mamot C. (2012) Targeting tumor-associated endothelial cells: anti-VEGFR2 immuno- liposomes mediate tumor vessel disruption and inhibit tu- mor growth. Clin Cancer Res 18, 454-464

  • –  MamotC.,RitschardR.,WickiA.,StehleG.,DieterleT., Bubendorf L., Hilker C., Deuster S., Herrmann R., Rochlitz C. (2012) Tolerability, safety, pharmacokinetics, and effica- cy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase I dose-escalation study. Lancet Oncol 13, 1234-1241

    Stenner F., Liewen H., Göttig S., Henschler R., Markuly N., Kleber S., Faust M., Mischo A., Bauser S., Zweifel M., Knuth A., Renner C., Wadle A.(2013) RP1 is a phospho- rylation target of CK2 and is involved in cell adhesion. PLoS One 8, e67595